Vanc Pharmaceuticals Inc. (
TSX: V.NPH,
Stock Forum) eased 10% to 18 cents after the company said it has received Natural Product Number approvals for four products from Health Canada.
Approvals have been received for FerroHEME (heme-iron supplement), PEDIA-SAFE drops (multivitamin dietary supplement for infant and children), SennaLax (natural laxative) and T36 Ointment (disinfectant and corticosteroid), the company said in a press release.
The NPN approvals allow Vanc to manufacture, market and sell all four products immediately.
| Select Canadian Small/Micro-cap Advancers (as of 4:00 PM Eastern) |
| Titan Medical Inc. (V.TMD, Stock Forum) |
18.38% |
| Cynapsus Therapeutics Inc. (V.CTH, Stock Forum) |
17.05% |
| Cardiff Energy Corp. (V.CRS, Stock Forum) |
14.71% |
| Horizons BetaPro S&P\/TSX Global Gold Bear Plus ETF (T.HGD, Stock Forum) |
10.97% |
| Patient Home Monitoring Corp. (V.PHM, Stock Forum) |
10.34% |
| Select Canadian Small/Micro-cap Decliners (as of 4:00 PM Eastern) |
| CYGAM Energy Inc. (V.CYG, Stock Forum) |
-40.00% |
| Allied Nevada Gold Corp. (T.ANV, Stock Forum) |
-26.96% |
| Sandstorm Gold Ltd. (T.SSL, Stock Forum) |
-12.50% |
| Nuvo Research Inc. (T.NRI, Stock Forum) |
-12.18% |
| Iona Energy Inc. (V.INA, Stock Forum) |
-11.54% |